US Stock MarketDetailed Quotes

ALPMY Astellas Pharma (ADR)

Watchlist
  • 9.670
  • -0.010-0.10%
15min DelayTrading Jan 7 10:03 ET
17.31BMarket Cap50.10P/E (TTM)

Astellas Pharma (ADR) Key Stats

Astellas Pharma (ADR) Q3 2025 Estimates Date

Currency:USDFeb 4, 2025

Estimate YoY
Revenue
2.86B
-4.37%
No Data

Astellas Pharma (ADR) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 414.065B--
Feb 4, 20252025/Q3-- / 448.790B--
Oct 30, 20242025/Q2462.497B / 425.282B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 414.065B--
Feb 4, 20252025/Q3-- / 448.790B--
Oct 30, 20242025/Q2462.497B / 425.282B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--

Unlock Free Earnings Estimates

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.